Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled date : 2022 - 07 - 25 save search
Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 3.39%
H: 0.42%
C: -1.6%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.96%
H: 0.47%
C: -0.08%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.17%
H: 0.48%
C: 0.17%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.62%
H: 1.09%
C: 0.23%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.37%
H: 1.66%
C: 0.6%
drug global market
Global Topical Drug Delivery Market Report to 2027 - Featuring Nestle, GlaxoSmithKline and Novartis Among Others
Published: 2022-07-25 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
TARO | $42.23 -0.07% 0.0% 23K
|
Health Technology
|
| O: 0.08%
H: 3.37%
C: -1.86%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
drug global report novartis market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.97 6.2% 2.21% 400K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
fda biosimilar ema sclerosis multiple sclerosis
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.